Global PCSK9 Targeted Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
PCSK9-targeted drugs are a class of medications designed to lower low-density lipoprotein cholesterol (LDL-C) levels in the blood,thereby reducing the risk of cardiovascular events.PCSK9 inhibitors are used primarily in patients with high cholesterol who have not achieved adequate lipid control with statins alone or have familial hypercholesterolemia.
The global PCSK9 Targeted Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “PCSK9 Targeted Drugs Industry Forecast” looks at past sales and reviews total world PCSK9 Targeted Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected PCSK9 Targeted Drugs sales for 2024 through 2030. With PCSK9 Targeted Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PCSK9 Targeted Drugs industry.
This Insight Report provides a comprehensive analysis of the global PCSK9 Targeted Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PCSK9 Targeted Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PCSK9 Targeted Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PCSK9 Targeted Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PCSK9 Targeted Drugs.
United States market for PCSK9 Targeted Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for PCSK9 Targeted Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for PCSK9 Targeted Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key PCSK9 Targeted Drugs players cover Regeneron Pharmaceuticals, Sanofi, Novartis, Innovent Biologics, Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of PCSK9 Targeted Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global PCSK9 Targeted Drugs market?
What factors are driving PCSK9 Targeted Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PCSK9 Targeted Drugs market opportunities vary by end market size?
How does PCSK9 Targeted Drugs break out by Type, by Application?
PCSK9-targeted drugs are a class of medications designed to lower low-density lipoprotein cholesterol (LDL-C) levels in the blood,thereby reducing the risk of cardiovascular events.PCSK9 inhibitors are used primarily in patients with high cholesterol who have not achieved adequate lipid control with statins alone or have familial hypercholesterolemia.
The global PCSK9 Targeted Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “PCSK9 Targeted Drugs Industry Forecast” looks at past sales and reviews total world PCSK9 Targeted Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected PCSK9 Targeted Drugs sales for 2024 through 2030. With PCSK9 Targeted Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PCSK9 Targeted Drugs industry.
This Insight Report provides a comprehensive analysis of the global PCSK9 Targeted Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PCSK9 Targeted Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PCSK9 Targeted Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PCSK9 Targeted Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PCSK9 Targeted Drugs.
United States market for PCSK9 Targeted Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for PCSK9 Targeted Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for PCSK9 Targeted Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key PCSK9 Targeted Drugs players cover Regeneron Pharmaceuticals, Sanofi, Novartis, Innovent Biologics, Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of PCSK9 Targeted Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Alirocumab
- Evolocumab
- Tafolecimab
- Inclisiran
- Hypercholesterolemia
- Combined Hyperlipidemia
- Heart Disease and Stroke Prevention
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Regeneron Pharmaceuticals
- Sanofi
- Novartis
- Innovent Biologics
- Amgen
What is the 10-year outlook for the global PCSK9 Targeted Drugs market?
What factors are driving PCSK9 Targeted Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PCSK9 Targeted Drugs market opportunities vary by end market size?
How does PCSK9 Targeted Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PCSK9 Targeted Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for PCSK9 Targeted Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for PCSK9 Targeted Drugs by Country/Region, 2019, 2023 & 2030
2.2 PCSK9 Targeted Drugs Segment by Type
2.2.1 Alirocumab
2.2.2 Evolocumab
2.2.3 Tafolecimab
2.2.4 Inclisiran
2.3 PCSK9 Targeted Drugs Sales by Type
2.3.1 Global PCSK9 Targeted Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global PCSK9 Targeted Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global PCSK9 Targeted Drugs Sale Price by Type (2019-2024)
2.4 PCSK9 Targeted Drugs Segment by Application
2.4.1 Hypercholesterolemia
2.4.2 Combined Hyperlipidemia
2.4.3 Heart Disease and Stroke Prevention
2.4.4 Other
2.5 PCSK9 Targeted Drugs Sales by Application
2.5.1 Global PCSK9 Targeted Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global PCSK9 Targeted Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global PCSK9 Targeted Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global PCSK9 Targeted Drugs Breakdown Data by Company
3.1.1 Global PCSK9 Targeted Drugs Annual Sales by Company (2019-2024)
3.1.2 Global PCSK9 Targeted Drugs Sales Market Share by Company (2019-2024)
3.2 Global PCSK9 Targeted Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global PCSK9 Targeted Drugs Revenue by Company (2019-2024)
3.2.2 Global PCSK9 Targeted Drugs Revenue Market Share by Company (2019-2024)
3.3 Global PCSK9 Targeted Drugs Sale Price by Company
3.4 Key Manufacturers PCSK9 Targeted Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PCSK9 Targeted Drugs Product Location Distribution
3.4.2 Players PCSK9 Targeted Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PCSK9 TARGETED DRUGS BY GEOGRAPHIC REGION
4.1 World Historic PCSK9 Targeted Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global PCSK9 Targeted Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global PCSK9 Targeted Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic PCSK9 Targeted Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global PCSK9 Targeted Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global PCSK9 Targeted Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas PCSK9 Targeted Drugs Sales Growth
4.4 APAC PCSK9 Targeted Drugs Sales Growth
4.5 Europe PCSK9 Targeted Drugs Sales Growth
4.6 Middle East & Africa PCSK9 Targeted Drugs Sales Growth
5 AMERICAS
5.1 Americas PCSK9 Targeted Drugs Sales by Country
5.1.1 Americas PCSK9 Targeted Drugs Sales by Country (2019-2024)
5.1.2 Americas PCSK9 Targeted Drugs Revenue by Country (2019-2024)
5.2 Americas PCSK9 Targeted Drugs Sales by Type (2019-2024)
5.3 Americas PCSK9 Targeted Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PCSK9 Targeted Drugs Sales by Region
6.1.1 APAC PCSK9 Targeted Drugs Sales by Region (2019-2024)
6.1.2 APAC PCSK9 Targeted Drugs Revenue by Region (2019-2024)
6.2 APAC PCSK9 Targeted Drugs Sales by Type (2019-2024)
6.3 APAC PCSK9 Targeted Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PCSK9 Targeted Drugs by Country
7.1.1 Europe PCSK9 Targeted Drugs Sales by Country (2019-2024)
7.1.2 Europe PCSK9 Targeted Drugs Revenue by Country (2019-2024)
7.2 Europe PCSK9 Targeted Drugs Sales by Type (2019-2024)
7.3 Europe PCSK9 Targeted Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PCSK9 Targeted Drugs by Country
8.1.1 Middle East & Africa PCSK9 Targeted Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa PCSK9 Targeted Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa PCSK9 Targeted Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa PCSK9 Targeted Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PCSK9 Targeted Drugs
10.3 Manufacturing Process Analysis of PCSK9 Targeted Drugs
10.4 Industry Chain Structure of PCSK9 Targeted Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PCSK9 Targeted Drugs Distributors
11.3 PCSK9 Targeted Drugs Customer
12 WORLD FORECAST REVIEW FOR PCSK9 TARGETED DRUGS BY GEOGRAPHIC REGION
12.1 Global PCSK9 Targeted Drugs Market Size Forecast by Region
12.1.1 Global PCSK9 Targeted Drugs Forecast by Region (2025-2030)
12.1.2 Global PCSK9 Targeted Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global PCSK9 Targeted Drugs Forecast by Type (2025-2030)
12.7 Global PCSK9 Targeted Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Regeneron Pharmaceuticals
13.1.1 Regeneron Pharmaceuticals Company Information
13.1.2 Regeneron Pharmaceuticals PCSK9 Targeted Drugs Product Portfolios and Specifications
13.1.3 Regeneron Pharmaceuticals PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Regeneron Pharmaceuticals Main Business Overview
13.1.5 Regeneron Pharmaceuticals Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi PCSK9 Targeted Drugs Product Portfolios and Specifications
13.2.3 Sanofi PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis PCSK9 Targeted Drugs Product Portfolios and Specifications
13.3.3 Novartis PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Innovent Biologics
13.4.1 Innovent Biologics Company Information
13.4.2 Innovent Biologics PCSK9 Targeted Drugs Product Portfolios and Specifications
13.4.3 Innovent Biologics PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Innovent Biologics Main Business Overview
13.4.5 Innovent Biologics Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen PCSK9 Targeted Drugs Product Portfolios and Specifications
13.5.3 Amgen PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. PCSK9Targeted Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. PCSK9Targeted Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Alirocumab
Table 4. Major Players of Evolocumab
Table 5. Major Players ofTafolecimab
Table 6. Major Players of Inclisiran
Table 7. Global PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 8. Global PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Table 9. Global PCSK9Targeted Drugs Revenue byType (2019-2024) & ($ million)
Table 10. Global PCSK9Targeted Drugs Revenue Market Share byType (2019-2024)
Table 11. Global PCSK9Targeted Drugs Sale Price byType (2019-2024) & (US$/Unit)
Table 12. Global PCSK9Targeted Drugs Sale by Application (2019-2024) & (K Units)
Table 13. Global PCSK9Targeted Drugs Sale Market Share by Application (2019-2024)
Table 14. Global PCSK9Targeted Drugs Revenue by Application (2019-2024) & ($ million)
Table 15. Global PCSK9Targeted Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global PCSK9Targeted Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global PCSK9Targeted Drugs Sales by Company (2019-2024) & (K Units)
Table 18. Global PCSK9Targeted Drugs Sales Market Share by Company (2019-2024)
Table 19. Global PCSK9Targeted Drugs Revenue by Company (2019-2024) & ($ millions)
Table 20. Global PCSK9Targeted Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global PCSK9Targeted Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers PCSK9Targeted Drugs Producing Area Distribution and Sales Area
Table 23. Players PCSK9Targeted Drugs Products Offered
Table 24. PCSK9Targeted Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global PCSK9Targeted Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global PCSK9Targeted Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global PCSK9Targeted Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global PCSK9Targeted Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global PCSK9Targeted Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global PCSK9Targeted Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global PCSK9Targeted Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global PCSK9Targeted Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas PCSK9Targeted Drugs Sales by Country (2019-2024) & (K Units)
Table 36. Americas PCSK9Targeted Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas PCSK9Targeted Drugs Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 39. Americas PCSK9Targeted Drugs Sales by Application (2019-2024) & (K Units)
Table 40. APAC PCSK9Targeted Drugs Sales by Region (2019-2024) & (K Units)
Table 41. APAC PCSK9Targeted Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC PCSK9Targeted Drugs Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 44. APAC PCSK9Targeted Drugs Sales by Application (2019-2024) & (K Units)
Table 45. Europe PCSK9Targeted Drugs Sales by Country (2019-2024) & (K Units)
Table 46. Europe PCSK9Targeted Drugs Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 48. Europe PCSK9Targeted Drugs Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa PCSK9Targeted Drugs Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa PCSK9Targeted Drugs Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 52. Middle East & Africa PCSK9Targeted Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of PCSK9Targeted Drugs
Table 54. Key Market Challenges & Risks of PCSK9Targeted Drugs
Table 55. Key IndustryTrends of PCSK9Targeted Drugs
Table 56. PCSK9Targeted Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. PCSK9Targeted Drugs Distributors List
Table 59. PCSK9Targeted Drugs Customer List
Table 60. Global PCSK9Targeted Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 61. Global PCSK9Targeted Drugs RevenueForecast by Region (2025-2030) & ($ millions)
Table 62. Americas PCSK9Targeted Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 63. Americas PCSK9Targeted Drugs Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 64. APAC PCSK9Targeted Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 65. APAC PCSK9Targeted Drugs Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 66. Europe PCSK9Targeted Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 67. Europe PCSK9Targeted Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa PCSK9Targeted Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa PCSK9Targeted Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 70. Global PCSK9Targeted Drugs SalesForecast byType (2025-2030) & (K Units)
Table 71. Global PCSK9Targeted Drugs RevenueForecast byType (2025-2030) & ($ millions)
Table 72. Global PCSK9Targeted Drugs SalesForecast by Application (2025-2030) & (K Units)
Table 73. Global PCSK9Targeted Drugs RevenueForecast by Application (2025-2030) & ($ millions)
Table 74. Regeneron Pharmaceuticals Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Regeneron Pharmaceuticals PCSK9Targeted Drugs Product Portfolios and Specifications
Table 76. Regeneron Pharmaceuticals PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Regeneron Pharmaceuticals Main Business
Table 78. Regeneron Pharmaceuticals Latest Developments
Table 79. Sanofi Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi PCSK9Targeted Drugs Product Portfolios and Specifications
Table 81. Sanofi PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Novartis Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis PCSK9Targeted Drugs Product Portfolios and Specifications
Table 86. Novartis PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Innovent Biologics Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Innovent Biologics PCSK9Targeted Drugs Product Portfolios and Specifications
Table 91. Innovent Biologics PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Innovent Biologics Main Business
Table 93. Innovent Biologics Latest Developments
Table 94. Amgen Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Amgen PCSK9Targeted Drugs Product Portfolios and Specifications
Table 96. Amgen PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Amgen Main Business
Table 98. Amgen Latest Developments
LIST OFFIGURES
Figure 1. Picture of PCSK9Targeted Drugs
Figure 2. PCSK9Targeted Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PCSK9Targeted Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global PCSK9Targeted Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. PCSK9Targeted Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. PCSK9Targeted Drugs Sales Market Share by Country/Region (2023)
Figure 10. PCSK9Targeted Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Alirocumab
Figure 12. Product Picture of Evolocumab
Figure 13. Product Picture ofTafolecimab
Figure 14. Product Picture of Inclisiran
Figure 15. Global PCSK9Targeted Drugs Sales Market Share byType in 2023
Figure 16. Global PCSK9Targeted Drugs Revenue Market Share byType (2019-2024)
Figure 17. PCSK9Targeted Drugs Consumed in Hypercholesterolemia
Figure 18. Global PCSK9Targeted Drugs Market: Hypercholesterolemia (2019-2024) & (K Units)
Figure 19. PCSK9Targeted Drugs Consumed in Combined Hyperlipidemia
Figure 20. Global PCSK9Targeted Drugs Market: Combined Hyperlipidemia (2019-2024) & (K Units)
Figure 21. PCSK9Targeted Drugs Consumed in Heart Disease and Stroke Prevention
Figure 22. Global PCSK9Targeted Drugs Market: Heart Disease and Stroke Prevention (2019-2024) & (K Units)
Figure 23. PCSK9Targeted Drugs Consumed in Other
Figure 24. Global PCSK9Targeted Drugs Market: Other (2019-2024) & (K Units)
Figure 25. Global PCSK9Targeted Drugs Sale Market Share by Application (2023)
Figure 26. Global PCSK9Targeted Drugs Revenue Market Share by Application in 2023
Figure 27. PCSK9Targeted Drugs Sales by Company in 2023 (K Units)
Figure 28. Global PCSK9Targeted Drugs Sales Market Share by Company in 2023
Figure 29. PCSK9Targeted Drugs Revenue by Company in 2023 ($ millions)
Figure 30. Global PCSK9Targeted Drugs Revenue Market Share by Company in 2023
Figure 31. Global PCSK9Targeted Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global PCSK9Targeted Drugs Revenue Market Share by Geographic Region in 2023
Figure 33. Americas PCSK9Targeted Drugs Sales 2019-2024 (K Units)
Figure 34. Americas PCSK9Targeted Drugs Revenue 2019-2024 ($ millions)
Figure 35. APAC PCSK9Targeted Drugs Sales 2019-2024 (K Units)
Figure 36. APAC PCSK9Targeted Drugs Revenue 2019-2024 ($ millions)
Figure 37. Europe PCSK9Targeted Drugs Sales 2019-2024 (K Units)
Figure 38. Europe PCSK9Targeted Drugs Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa PCSK9Targeted Drugs Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa PCSK9Targeted Drugs Revenue 2019-2024 ($ millions)
Figure 41. Americas PCSK9Targeted Drugs Sales Market Share by Country in 2023
Figure 42. Americas PCSK9Targeted Drugs Revenue Market Share by Country (2019-2024)
Figure 43. Americas PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Figure 44. Americas PCSK9Targeted Drugs Sales Market Share by Application (2019-2024)
Figure 45. United States PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC PCSK9Targeted Drugs Sales Market Share by Region in 2023
Figure 50. APAC PCSK9Targeted Drugs Revenue Market Share by Region (2019-2024)
Figure 51. APAC PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Figure 52. APAC PCSK9Targeted Drugs Sales Market Share by Application (2019-2024)
Figure 53. China PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. India PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 59. ChinaTaiwan PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe PCSK9Targeted Drugs Sales Market Share by Country in 2023
Figure 61. Europe PCSK9Targeted Drugs Revenue Market Share by Country (2019-2024)
Figure 62. Europe PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Figure 63. Europe PCSK9Targeted Drugs Sales Market Share by Application (2019-2024)
Figure 64. Germany PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65.France PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. UK PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa PCSK9Targeted Drugs Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Figure 71. Middle East & Africa PCSK9Targeted Drugs Sales Market Share by Application (2019-2024)
Figure 72. Egypt PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 75.Turkey PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of PCSK9Targeted Drugs in 2023
Figure 78. Manufacturing Process Analysis of PCSK9Targeted Drugs
Figure 79. Industry Chain Structure of PCSK9Targeted Drugs
Figure 80. Channels of Distribution
Figure 81. Global PCSK9Targeted Drugs Sales MarketForecast by Region (2025-2030)
Figure 82. Global PCSK9Targeted Drugs Revenue Market ShareForecast by Region (2025-2030)
Figure 83. Global PCSK9Targeted Drugs Sales Market ShareForecast byType (2025-2030)
Figure 84. Global PCSK9Targeted Drugs Revenue Market ShareForecast byType (2025-2030)
Figure 85. Global PCSK9Targeted Drugs Sales Market ShareForecast by Application (2025-2030)
Figure 86. Global PCSK9Targeted Drugs Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PCSK9 Targeted Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for PCSK9 Targeted Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for PCSK9 Targeted Drugs by Country/Region, 2019, 2023 & 2030
2.2 PCSK9 Targeted Drugs Segment by Type
2.2.1 Alirocumab
2.2.2 Evolocumab
2.2.3 Tafolecimab
2.2.4 Inclisiran
2.3 PCSK9 Targeted Drugs Sales by Type
2.3.1 Global PCSK9 Targeted Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global PCSK9 Targeted Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global PCSK9 Targeted Drugs Sale Price by Type (2019-2024)
2.4 PCSK9 Targeted Drugs Segment by Application
2.4.1 Hypercholesterolemia
2.4.2 Combined Hyperlipidemia
2.4.3 Heart Disease and Stroke Prevention
2.4.4 Other
2.5 PCSK9 Targeted Drugs Sales by Application
2.5.1 Global PCSK9 Targeted Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global PCSK9 Targeted Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global PCSK9 Targeted Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global PCSK9 Targeted Drugs Breakdown Data by Company
3.1.1 Global PCSK9 Targeted Drugs Annual Sales by Company (2019-2024)
3.1.2 Global PCSK9 Targeted Drugs Sales Market Share by Company (2019-2024)
3.2 Global PCSK9 Targeted Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global PCSK9 Targeted Drugs Revenue by Company (2019-2024)
3.2.2 Global PCSK9 Targeted Drugs Revenue Market Share by Company (2019-2024)
3.3 Global PCSK9 Targeted Drugs Sale Price by Company
3.4 Key Manufacturers PCSK9 Targeted Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PCSK9 Targeted Drugs Product Location Distribution
3.4.2 Players PCSK9 Targeted Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PCSK9 TARGETED DRUGS BY GEOGRAPHIC REGION
4.1 World Historic PCSK9 Targeted Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global PCSK9 Targeted Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global PCSK9 Targeted Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic PCSK9 Targeted Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global PCSK9 Targeted Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global PCSK9 Targeted Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas PCSK9 Targeted Drugs Sales Growth
4.4 APAC PCSK9 Targeted Drugs Sales Growth
4.5 Europe PCSK9 Targeted Drugs Sales Growth
4.6 Middle East & Africa PCSK9 Targeted Drugs Sales Growth
5 AMERICAS
5.1 Americas PCSK9 Targeted Drugs Sales by Country
5.1.1 Americas PCSK9 Targeted Drugs Sales by Country (2019-2024)
5.1.2 Americas PCSK9 Targeted Drugs Revenue by Country (2019-2024)
5.2 Americas PCSK9 Targeted Drugs Sales by Type (2019-2024)
5.3 Americas PCSK9 Targeted Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PCSK9 Targeted Drugs Sales by Region
6.1.1 APAC PCSK9 Targeted Drugs Sales by Region (2019-2024)
6.1.2 APAC PCSK9 Targeted Drugs Revenue by Region (2019-2024)
6.2 APAC PCSK9 Targeted Drugs Sales by Type (2019-2024)
6.3 APAC PCSK9 Targeted Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PCSK9 Targeted Drugs by Country
7.1.1 Europe PCSK9 Targeted Drugs Sales by Country (2019-2024)
7.1.2 Europe PCSK9 Targeted Drugs Revenue by Country (2019-2024)
7.2 Europe PCSK9 Targeted Drugs Sales by Type (2019-2024)
7.3 Europe PCSK9 Targeted Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PCSK9 Targeted Drugs by Country
8.1.1 Middle East & Africa PCSK9 Targeted Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa PCSK9 Targeted Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa PCSK9 Targeted Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa PCSK9 Targeted Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PCSK9 Targeted Drugs
10.3 Manufacturing Process Analysis of PCSK9 Targeted Drugs
10.4 Industry Chain Structure of PCSK9 Targeted Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PCSK9 Targeted Drugs Distributors
11.3 PCSK9 Targeted Drugs Customer
12 WORLD FORECAST REVIEW FOR PCSK9 TARGETED DRUGS BY GEOGRAPHIC REGION
12.1 Global PCSK9 Targeted Drugs Market Size Forecast by Region
12.1.1 Global PCSK9 Targeted Drugs Forecast by Region (2025-2030)
12.1.2 Global PCSK9 Targeted Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global PCSK9 Targeted Drugs Forecast by Type (2025-2030)
12.7 Global PCSK9 Targeted Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Regeneron Pharmaceuticals
13.1.1 Regeneron Pharmaceuticals Company Information
13.1.2 Regeneron Pharmaceuticals PCSK9 Targeted Drugs Product Portfolios and Specifications
13.1.3 Regeneron Pharmaceuticals PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Regeneron Pharmaceuticals Main Business Overview
13.1.5 Regeneron Pharmaceuticals Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi PCSK9 Targeted Drugs Product Portfolios and Specifications
13.2.3 Sanofi PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis PCSK9 Targeted Drugs Product Portfolios and Specifications
13.3.3 Novartis PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Innovent Biologics
13.4.1 Innovent Biologics Company Information
13.4.2 Innovent Biologics PCSK9 Targeted Drugs Product Portfolios and Specifications
13.4.3 Innovent Biologics PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Innovent Biologics Main Business Overview
13.4.5 Innovent Biologics Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen PCSK9 Targeted Drugs Product Portfolios and Specifications
13.5.3 Amgen PCSK9 Targeted Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. PCSK9Targeted Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. PCSK9Targeted Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Alirocumab
Table 4. Major Players of Evolocumab
Table 5. Major Players ofTafolecimab
Table 6. Major Players of Inclisiran
Table 7. Global PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 8. Global PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Table 9. Global PCSK9Targeted Drugs Revenue byType (2019-2024) & ($ million)
Table 10. Global PCSK9Targeted Drugs Revenue Market Share byType (2019-2024)
Table 11. Global PCSK9Targeted Drugs Sale Price byType (2019-2024) & (US$/Unit)
Table 12. Global PCSK9Targeted Drugs Sale by Application (2019-2024) & (K Units)
Table 13. Global PCSK9Targeted Drugs Sale Market Share by Application (2019-2024)
Table 14. Global PCSK9Targeted Drugs Revenue by Application (2019-2024) & ($ million)
Table 15. Global PCSK9Targeted Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global PCSK9Targeted Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global PCSK9Targeted Drugs Sales by Company (2019-2024) & (K Units)
Table 18. Global PCSK9Targeted Drugs Sales Market Share by Company (2019-2024)
Table 19. Global PCSK9Targeted Drugs Revenue by Company (2019-2024) & ($ millions)
Table 20. Global PCSK9Targeted Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global PCSK9Targeted Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers PCSK9Targeted Drugs Producing Area Distribution and Sales Area
Table 23. Players PCSK9Targeted Drugs Products Offered
Table 24. PCSK9Targeted Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global PCSK9Targeted Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global PCSK9Targeted Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global PCSK9Targeted Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global PCSK9Targeted Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global PCSK9Targeted Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global PCSK9Targeted Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global PCSK9Targeted Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global PCSK9Targeted Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas PCSK9Targeted Drugs Sales by Country (2019-2024) & (K Units)
Table 36. Americas PCSK9Targeted Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas PCSK9Targeted Drugs Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 39. Americas PCSK9Targeted Drugs Sales by Application (2019-2024) & (K Units)
Table 40. APAC PCSK9Targeted Drugs Sales by Region (2019-2024) & (K Units)
Table 41. APAC PCSK9Targeted Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC PCSK9Targeted Drugs Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 44. APAC PCSK9Targeted Drugs Sales by Application (2019-2024) & (K Units)
Table 45. Europe PCSK9Targeted Drugs Sales by Country (2019-2024) & (K Units)
Table 46. Europe PCSK9Targeted Drugs Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 48. Europe PCSK9Targeted Drugs Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa PCSK9Targeted Drugs Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa PCSK9Targeted Drugs Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa PCSK9Targeted Drugs Sales byType (2019-2024) & (K Units)
Table 52. Middle East & Africa PCSK9Targeted Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of PCSK9Targeted Drugs
Table 54. Key Market Challenges & Risks of PCSK9Targeted Drugs
Table 55. Key IndustryTrends of PCSK9Targeted Drugs
Table 56. PCSK9Targeted Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. PCSK9Targeted Drugs Distributors List
Table 59. PCSK9Targeted Drugs Customer List
Table 60. Global PCSK9Targeted Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 61. Global PCSK9Targeted Drugs RevenueForecast by Region (2025-2030) & ($ millions)
Table 62. Americas PCSK9Targeted Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 63. Americas PCSK9Targeted Drugs Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 64. APAC PCSK9Targeted Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 65. APAC PCSK9Targeted Drugs Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 66. Europe PCSK9Targeted Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 67. Europe PCSK9Targeted Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa PCSK9Targeted Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa PCSK9Targeted Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 70. Global PCSK9Targeted Drugs SalesForecast byType (2025-2030) & (K Units)
Table 71. Global PCSK9Targeted Drugs RevenueForecast byType (2025-2030) & ($ millions)
Table 72. Global PCSK9Targeted Drugs SalesForecast by Application (2025-2030) & (K Units)
Table 73. Global PCSK9Targeted Drugs RevenueForecast by Application (2025-2030) & ($ millions)
Table 74. Regeneron Pharmaceuticals Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Regeneron Pharmaceuticals PCSK9Targeted Drugs Product Portfolios and Specifications
Table 76. Regeneron Pharmaceuticals PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Regeneron Pharmaceuticals Main Business
Table 78. Regeneron Pharmaceuticals Latest Developments
Table 79. Sanofi Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi PCSK9Targeted Drugs Product Portfolios and Specifications
Table 81. Sanofi PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Novartis Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis PCSK9Targeted Drugs Product Portfolios and Specifications
Table 86. Novartis PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Innovent Biologics Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Innovent Biologics PCSK9Targeted Drugs Product Portfolios and Specifications
Table 91. Innovent Biologics PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Innovent Biologics Main Business
Table 93. Innovent Biologics Latest Developments
Table 94. Amgen Basic Information, PCSK9Targeted Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Amgen PCSK9Targeted Drugs Product Portfolios and Specifications
Table 96. Amgen PCSK9Targeted Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Amgen Main Business
Table 98. Amgen Latest Developments
LIST OFFIGURES
Figure 1. Picture of PCSK9Targeted Drugs
Figure 2. PCSK9Targeted Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PCSK9Targeted Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global PCSK9Targeted Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. PCSK9Targeted Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. PCSK9Targeted Drugs Sales Market Share by Country/Region (2023)
Figure 10. PCSK9Targeted Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Alirocumab
Figure 12. Product Picture of Evolocumab
Figure 13. Product Picture ofTafolecimab
Figure 14. Product Picture of Inclisiran
Figure 15. Global PCSK9Targeted Drugs Sales Market Share byType in 2023
Figure 16. Global PCSK9Targeted Drugs Revenue Market Share byType (2019-2024)
Figure 17. PCSK9Targeted Drugs Consumed in Hypercholesterolemia
Figure 18. Global PCSK9Targeted Drugs Market: Hypercholesterolemia (2019-2024) & (K Units)
Figure 19. PCSK9Targeted Drugs Consumed in Combined Hyperlipidemia
Figure 20. Global PCSK9Targeted Drugs Market: Combined Hyperlipidemia (2019-2024) & (K Units)
Figure 21. PCSK9Targeted Drugs Consumed in Heart Disease and Stroke Prevention
Figure 22. Global PCSK9Targeted Drugs Market: Heart Disease and Stroke Prevention (2019-2024) & (K Units)
Figure 23. PCSK9Targeted Drugs Consumed in Other
Figure 24. Global PCSK9Targeted Drugs Market: Other (2019-2024) & (K Units)
Figure 25. Global PCSK9Targeted Drugs Sale Market Share by Application (2023)
Figure 26. Global PCSK9Targeted Drugs Revenue Market Share by Application in 2023
Figure 27. PCSK9Targeted Drugs Sales by Company in 2023 (K Units)
Figure 28. Global PCSK9Targeted Drugs Sales Market Share by Company in 2023
Figure 29. PCSK9Targeted Drugs Revenue by Company in 2023 ($ millions)
Figure 30. Global PCSK9Targeted Drugs Revenue Market Share by Company in 2023
Figure 31. Global PCSK9Targeted Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global PCSK9Targeted Drugs Revenue Market Share by Geographic Region in 2023
Figure 33. Americas PCSK9Targeted Drugs Sales 2019-2024 (K Units)
Figure 34. Americas PCSK9Targeted Drugs Revenue 2019-2024 ($ millions)
Figure 35. APAC PCSK9Targeted Drugs Sales 2019-2024 (K Units)
Figure 36. APAC PCSK9Targeted Drugs Revenue 2019-2024 ($ millions)
Figure 37. Europe PCSK9Targeted Drugs Sales 2019-2024 (K Units)
Figure 38. Europe PCSK9Targeted Drugs Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa PCSK9Targeted Drugs Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa PCSK9Targeted Drugs Revenue 2019-2024 ($ millions)
Figure 41. Americas PCSK9Targeted Drugs Sales Market Share by Country in 2023
Figure 42. Americas PCSK9Targeted Drugs Revenue Market Share by Country (2019-2024)
Figure 43. Americas PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Figure 44. Americas PCSK9Targeted Drugs Sales Market Share by Application (2019-2024)
Figure 45. United States PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC PCSK9Targeted Drugs Sales Market Share by Region in 2023
Figure 50. APAC PCSK9Targeted Drugs Revenue Market Share by Region (2019-2024)
Figure 51. APAC PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Figure 52. APAC PCSK9Targeted Drugs Sales Market Share by Application (2019-2024)
Figure 53. China PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. India PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 59. ChinaTaiwan PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe PCSK9Targeted Drugs Sales Market Share by Country in 2023
Figure 61. Europe PCSK9Targeted Drugs Revenue Market Share by Country (2019-2024)
Figure 62. Europe PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Figure 63. Europe PCSK9Targeted Drugs Sales Market Share by Application (2019-2024)
Figure 64. Germany PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65.France PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. UK PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa PCSK9Targeted Drugs Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa PCSK9Targeted Drugs Sales Market Share byType (2019-2024)
Figure 71. Middle East & Africa PCSK9Targeted Drugs Sales Market Share by Application (2019-2024)
Figure 72. Egypt PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 75.Turkey PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries PCSK9Targeted Drugs Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of PCSK9Targeted Drugs in 2023
Figure 78. Manufacturing Process Analysis of PCSK9Targeted Drugs
Figure 79. Industry Chain Structure of PCSK9Targeted Drugs
Figure 80. Channels of Distribution
Figure 81. Global PCSK9Targeted Drugs Sales MarketForecast by Region (2025-2030)
Figure 82. Global PCSK9Targeted Drugs Revenue Market ShareForecast by Region (2025-2030)
Figure 83. Global PCSK9Targeted Drugs Sales Market ShareForecast byType (2025-2030)
Figure 84. Global PCSK9Targeted Drugs Revenue Market ShareForecast byType (2025-2030)
Figure 85. Global PCSK9Targeted Drugs Sales Market ShareForecast by Application (2025-2030)
Figure 86. Global PCSK9Targeted Drugs Revenue Market ShareForecast by Application (2025-2030)
